rs147579402

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_133642.5(LARGE1):​c.788-29A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00678 in 1,565,854 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.0055 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 41 hom. )

Consequence

LARGE1
NM_133642.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0160

Publications

0 publications found
Variant links:
Genes affected
LARGE1 (HGNC:6511): (LARGE xylosyl- and glucuronyltransferase 1) This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]
LARGE1 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy type B6
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-33432294-T-C is Benign according to our data. Variant chr22-33432294-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 259536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00545 (830/152226) while in subpopulation NFE AF = 0.00835 (568/68006). AF 95% confidence interval is 0.00778. There are 7 homozygotes in GnomAd4. There are 407 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LARGE1NM_133642.5 linkc.788-29A>G intron_variant Intron 6 of 14 ENST00000397394.8 NP_598397.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LARGE1ENST00000397394.8 linkc.788-29A>G intron_variant Intron 6 of 14 5 NM_133642.5 ENSP00000380549.2

Frequencies

GnomAD3 genomes
AF:
0.00546
AC:
830
AN:
152108
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0144
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00835
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00590
AC:
1472
AN:
249682
AF XY:
0.00594
show subpopulations
Gnomad AFR exome
AF:
0.00124
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.00249
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0170
Gnomad NFE exome
AF:
0.00836
Gnomad OTH exome
AF:
0.00654
GnomAD4 exome
AF:
0.00692
AC:
9784
AN:
1413628
Hom.:
41
Cov.:
24
AF XY:
0.00671
AC XY:
4738
AN XY:
706342
show subpopulations
African (AFR)
AF:
0.00114
AC:
37
AN:
32534
American (AMR)
AF:
0.00186
AC:
83
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
0.00244
AC:
63
AN:
25828
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39454
South Asian (SAS)
AF:
0.000610
AC:
52
AN:
85182
European-Finnish (FIN)
AF:
0.0161
AC:
858
AN:
53294
Middle Eastern (MID)
AF:
0.000529
AC:
3
AN:
5666
European-Non Finnish (NFE)
AF:
0.00779
AC:
8326
AN:
1068294
Other (OTH)
AF:
0.00616
AC:
362
AN:
58762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
481
962
1444
1925
2406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00545
AC:
830
AN:
152226
Hom.:
7
Cov.:
32
AF XY:
0.00547
AC XY:
407
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41540
American (AMR)
AF:
0.00203
AC:
31
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.0144
AC:
153
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00835
AC:
568
AN:
68006
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00720
Hom.:
3
Bravo
AF:
0.00412
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 08, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.8
DANN
Benign
0.76
PhyloP100
0.016
La Branchor
0.57
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147579402; hg19: chr22-33828280; API